105 related articles for article (PubMed ID: 8884220)
21. Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.
Stirnweiss J; Hartrodt B; Greksch G; Stürzebecher U; Böhmer FD; Neubert K; Liebmann C
Br J Pharmacol; 2003 Sep; 140(1):13-22. PubMed ID: 12967930
[TBL] [Abstract][Full Text] [Related]
22. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
Bowen WD; Kelemen M; Huey R; Stewart D
NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
[TBL] [Abstract][Full Text] [Related]
23. Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.
Zagon IS; McLaughlin PJ
Brain Res; 1989 Feb; 480(1-2):16-28. PubMed ID: 2540873
[TBL] [Abstract][Full Text] [Related]
24. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
25. Taxol inhibits opioid binding on T47D human breast cancer cells.
Bakogeorgou E; Hatzoglou A; Castanas E
Biochem Biophys Res Commun; 1997 Jun; 235(1):201-4. PubMed ID: 9196063
[TBL] [Abstract][Full Text] [Related]
26. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
27. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians.
Stevens CW
J Pharmacol Exp Ther; 1996 Feb; 276(2):440-8. PubMed ID: 8632308
[TBL] [Abstract][Full Text] [Related]
28. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
Tavani A; Petrillo P; La Regina A; Sbacchi M
J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
[TBL] [Abstract][Full Text] [Related]
29. Agonist activation of delta-opioid receptor but not mu-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner.
Law PY; McGinn TM; Campbell KM; Erickson LE; Loh HH
Mol Pharmacol; 1997 Jan; 51(1):152-60. PubMed ID: 9016358
[TBL] [Abstract][Full Text] [Related]
30. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
De Vries TJ; Schoffelmeer AN; Delay-Goyet P; Roques BP; Mulder AH
Eur J Pharmacol; 1989 Nov; 170(3):137-43. PubMed ID: 2575993
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin and opioid receptors in mammary tissue. Role in cancer cell growth.
Hatzoglou A; Bakogeorgou E; Kampa M; Panagiotou S; Martin PM; Loukas S; Castanas E
Adv Exp Med Biol; 2000; 480():55-63. PubMed ID: 10959409
[TBL] [Abstract][Full Text] [Related]
32. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
Kirby GC; McQueen DS
Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
Sánchez-Blázquez P; Garzón J
Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
[TBL] [Abstract][Full Text] [Related]
34. Opioid receptor types on adrenergic nerve terminals of rabbit ear artery.
Fukuda H; Hosoki E; Ishida Y; Moritoki H
Br J Pharmacol; 1985 Nov; 86(3):539-45. PubMed ID: 2998521
[TBL] [Abstract][Full Text] [Related]
35. Effect of casein and beta-casomorphins on gastrointestinal motility in rats.
Daniel H; Vohwinkel M; Rehner G
J Nutr; 1990 Mar; 120(3):252-7. PubMed ID: 2319342
[TBL] [Abstract][Full Text] [Related]
36. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
[TBL] [Abstract][Full Text] [Related]
37. Novel opiate binding sites selective for benzomorphan drugs.
Chang KJ; Hazum E; Cuatrecasas P
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
[TBL] [Abstract][Full Text] [Related]
38. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
39. Activation of mu- and delta-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion.
Rogers H; Henderson G
Br J Pharmacol; 1990 Nov; 101(3):505-12. PubMed ID: 1981687
[TBL] [Abstract][Full Text] [Related]
40. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]